ANALISI DELLE PRESCRIZIONI DI FARMACI ANTIEPILETTICI IN ITALIA NEGLI ULTIMI 4 ANNI

Abstract

The marketing data collected by the Istituto Misurazioni Statistiche (IMS) were computed in order to evaluate the prescription of AEDs over the last four years. On average, 40% of patients are on monotherapy. Out of the total number of prescriptions, PB accounts for 41%, followed by CBZ (17%), VPA (11%) and fixed combinations (11%), while benzodiazepines account for 4% of prescriptions. The prevalence of epilepsy on pharmacological treatments, assessed on the basis of the DDD-method (defined-daily-doses) is 5.1%